Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope Gene
AssigneesMerial Limited, Centre National De La Recherche Scientifique, Institut Gustave Roussy, Universite Paris-Sud
InventorsHerve Poulet, Thierry Heidmann
Life of this patent
Estimating the term…
Abstract
The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.
Claims20
1-25. (canceled)
A composition comprising an expression vector, wherein the vector comprises one or more polynucleotides encoding one or more polypeptides selected from the group consisting of an optimized FeLV polypeptide, a variant or fragment of the optimized FeLV polypeptide, and a mixture thereof.
An expression vector comprising one or more polynucleotides encoding one or more polypeptides selected from the group consisting of an optimized FeLV polypeptide, a variant or fragment of the optimized FeLV polypeptide, and a mixture thereof.
Dependencies are inferred from the claim text.